OCRA

OVARIAN CANCER RESEARCH ALLIANCE LAUNCHES INNOVATIVE "FIND A DOCTOR" TOOL TO EMPOWER PATIENTS NATIONWIDE

Retrieved on: 
Tuesday, April 9, 2024
Komodo, Diagnosis, Ovarian cancer, Database, Patient, Research, Oncology, Oncology nursing, Ovary, OCRA, Clinical trial, Geography, Ovarian Cancer Research Alliance, Physician, Birth control

NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Ovarian Cancer Research Alliance (OCRA) proudly unveiled its latest innovation in supporting individuals affected by ovarian and other gynecologic cancers: the "Find a Doctor" tool.

Key Points: 
  • NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Ovarian Cancer Research Alliance (OCRA) proudly unveiled its latest innovation in supporting individuals affected by ovarian and other gynecologic cancers: the "Find a Doctor" tool.
  • Navigating a diagnosis of ovarian or other gynecologic cancer can be overwhelming, and finding the right medical team is paramount to ensuring the best possible outcomes.
  • "Access to quality care is a critical issue of equity for patients," said Audra Moran, President and CEO of OCRA.
  • The new tool underscores OCRA's ongoing commitment to advancing research, raising awareness, and providing support to the ovarian cancer community.

OVARIAN CANCER RESEARCH ALLIANCE CELEBRATES LANDMARK YEAR OF ACHIEVEMENTS IN 2023, SURPASSING FUNDRAISING GOALS AND ACCELERATING RESEARCH IN GYNECOLOGIC CANCERS

Retrieved on: 
Wednesday, January 17, 2024
Patient, Ovarian cancer, Research, Congress, OCRA, Life, Knowledge, Medicare, Data wrangling, Survivor, Cancer, Risk, Quality of life, Oncology nursing, Genetic testing, Human, Ovarian Cancer Research Alliance, Ovary, Diagnosis, Birth control

"Historically, 2023 has been a year of unparalleled achievement for OCRA," said Audra Moran, President and CEO.

Key Points: 
  • "Historically, 2023 has been a year of unparalleled achievement for OCRA," said Audra Moran, President and CEO.
  • "Our achievements this year have bolstered our commitment and energized our efforts to drive significant progress in understanding, preventing, and treating ovarian and related gynecologic cancers."
  • Recognizing the interconnectedness of ovarian and related gynecologic cancers, OCRA expanded its mission accelerating progress, acknowledging commonalities between these diseases, and broadening our impact on patients' lives.
  • Ovarian Cancer Research Alliance (OCRA) is the largest global organization dedicated to advancing ovarian cancer research while supporting patients and their families.

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

Retrieved on: 
Tuesday, October 31, 2023
Ovarian cancer, Ovarian Cancer Research Alliance, Government, Hormone receptor, OCRA, Conference, Research, Woman, Cancer, Autotransplantation, SAN, Birth control

SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National Conference taking place from November 1 – 3, 2023.

Key Points: 
  • "We are pleased to be presenting at the Ovarian Cancer National Conference," said Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences.
  • "We look forward to providing an overview of our Phase 1 ovarian cancer trial to an audience which is highly interested in new therapies to battle ovarian cancer."
  • The Ovarian Cancer National Conference is organized by the Ovarian Cancer Research Alliance ("OCRA").
  • The organization has invested $100 million in ovarian cancer research, educated 95,000 medical professionals, and advocated for $200 million in government research and education funding.

Ovarian Cancer Research Alliance (OCRA) Closes Ovarian Cancer Awareness Month with Game-Changing Initiatives

Retrieved on: 
Tuesday, September 26, 2023
Ovarian Cancer Research Alliance, OCRA, Ovary, Hope, Ovarian cancer, Health, Research, Patient, Cancer, Birth control, Pharmaceutical industry

NEW YORK, Sept. 26, 2023 /PRNewswire/ -- As Ovarian Cancer Awareness Month draws to a close, Ovarian Cancer Research Alliance (OCRA) is announcing a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support:  OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian cancer and endometrial registry, and will initiate a groundbreaking international data commons.

Key Points: 
  • NEW YORK, Sept. 26, 2023 /PRNewswire/ -- As Ovarian Cancer Awareness Month draws to a close, Ovarian Cancer Research Alliance (OCRA) is announcing a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support:  OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian cancer and endometrial registry, and will initiate a groundbreaking international data commons.
  • Audra Moran, President and CEO of OCRA, stated, "This marks a pivotal moment in our fight against ovarian and related cancers.
  • Moran highlighted the significance of these initiatives: "Our commitment to this trio underscores our dedication to transforming ovarian and related cancer research and patient care.
  • These announcements reaffirm OCRA's commitment to propelling Ovarian Cancer Awareness Month into a catalyst for progress and providing hope for affected individuals and families.

2FA App Protectimus SMART OTP Unveils Advanced Encrypted Cloud Backup, Outshining Google Authenticator

Retrieved on: 
Wednesday, May 24, 2023
Exercise, Google Play, App store, OCRA, PIN, App Store (iOS/iPadOS), Google Authenticator, HOTP, Cryptocurrency, Mobile phone, Online shopping, Security printing

Dublin, Ireland, May 24, 2023 /PRNewswire-PRWeb/ -- Protectimus Limited, a trusted leader in two-factor authentication solutions, announces the release of the latest version of their free authenticator app Protectimus SMART OTP. The latest release delivers an end-to-end encrypted cloud backup feature, surpassing the capabilities of Google Authenticator. In addition, Protectimus SMART OTP users can now enjoy seamless token transfer, customizable tokens, PIN and biometric authentication, and an array of other features.

Key Points: 
  • Dublin, Ireland, May 24, 2023 /PRNewswire-PRWeb/ -- Protectimus Limited, a trusted leader in two-factor authentication solutions, announces the release of the latest version of their free authenticator app Protectimus SMART OTP.
  • Protectimus SMART and Google Authenticator are both popular 2FA apps that offer cloud backup as a feature.
  • "We're thrilled to introduce the latest version of our Protectimus SMART OTP authenticator app," said Maksym Oliinyk, Director of Protectimus Limited.
  • The updated Protectimus SMART OTP authenticator app is now available for download on the App Store and Google Play.

Comcast Signs Agreements with State of Indiana: Joint $50 Million Investment Will Bring Fiber Network to 10,000+ Rural Hoosiers Across 19 Counties

Retrieved on: 
Monday, February 6, 2023
Technology, Internet, Telecommunications, National Bank for Agriculture and Rural Development, ACP, OCRA, Veteran, Hoosier, Affordable Connectivity Program, Investment, Government Affairs Institute, Telehealth, Rural development, Parent, Student, Partnership, Education, Allen Bartholomew, Multimedia, Thorntown, Indiana, Indiana Office of Community & Rural Affairs, Community, Internet service provider, Cable television, Agriculture, Comcast

Comcast has signed contracts with Indiana’s Office of Community & Rural Affairs (OCRA) to bring gigabit-capable broadband service to unserved parts of Indiana.

Key Points: 
  • Comcast has signed contracts with Indiana’s Office of Community & Rural Affairs (OCRA) to bring gigabit-capable broadband service to unserved parts of Indiana.
  • View the full release here: https://www.businesswire.com/news/home/20230206005155/en/
    Comcast has signed contracts with Indiana’s Office of Community & Rural Affairs (OCRA) to bring gigabit-capable broadband service to unserved parts of Indiana.
  • Under this latest phase of Next Level Connections grants, Comcast is investing $36 million in conjunction with the state’s $13.6 million to expand its network.
  • In that time, Comcast has also invested more than $500 million to strengthen and expand its Indiana network.

OVARIAN CANCER LEADERS URGE GENETIC TESTING FOR INCREASED-RISK INDIVIDUALS, AND CONSIDERATION OF PROPHYLACTIC SURGERY FOR ALL WOMEN

Retrieved on: 
Wednesday, February 1, 2023
Society, Gynecologic Oncology (journal), Ovarian cancer, Science, Woman, Learning, OCRA, United Kingdom, Breast, Society of Gynecologic Oncology, Cancer, Salpingectomy, Patient, Ovarian Cancer Research Alliance, News, Research, Mortality, Risk, Tubing (recreation), Weapon, Risk management, Genetic testing, Multimedia, Gynecologic cancer disparities in the United States, Ovary, Mount Sinai Health System, MD, Birth control, Pharmaceutical industry

Until there is a cure, these are our best weapons in the battle against ovarian cancer.

Key Points: 
  • Until there is a cure, these are our best weapons in the battle against ovarian cancer.
  • "Ovarian cancer is considered a rare disease, but for those with a family history and/or genetic mutation, the risk jumps to 40-50% or even higher.
  • "This is incredibly hard information to accept and runs contrary to almost all messaging related to ovarian cancer awareness to date.
  • However, to ignore learnings gained from current research would be detrimental to the wellbeing of women and the future of ovarian cancer research," said Moran.

Brightspeed Announces Initial Fiber Build Markets for Indiana

Retrieved on: 
Tuesday, August 30, 2022
Newton, Apollo, NYSE, Telecommunication, Adams, Hoosier, OCRA, FTTP, FCC, Quality of life, Education, Community, ILEC, APO, Architecture, Digital divide, Internet, Indiana Office of Community & Rural Affairs, Acquisition, Growth, Lumen Technologies, Renewable energy, Internet service provider, Lagrange (disambiguation), White

CHARLOTTE, N.C., Aug. 30, 2022 /PRNewswire/ -- Brightspeed today announced details for its planned fiber optics network build in the state of Indiana. By the end of 2023, the company will deliver over 50,000 new fiber passings in portions of 20 counties during the first phase of construction in the state. Brightspeed plans an additional 70,000 fiber passings in subsequent years of its build plan, for a total of more than 120,000 fiber-enabled locations across its Indiana footprint.

Key Points: 
  • CHARLOTTE, N.C., Aug. 30, 2022 /PRNewswire/ -- Brightspeed today announced details for its planned fiber optics network build in the state of Indiana.
  • Brightspeed plans an additional 70,000 fiber passings in subsequent years of its build plan, for a total of more than 120,000 fiber-enabled locations across its Indiana footprint.
  • The Indiana fiber build is the latest in a series of announcements that Brightspeed has made over the last several months outlining the company's fiber network plans for its multistate territory.
  • "We are excited to share our fiber network upgrade plans for Indiana and are thrilled that we will be reaching so many communities during our initial build phase," said Tom Maguire, chief operating officer of Brightspeed.

Newk's Debuts 9 All-New Signature Menu Items

Retrieved on: 
Wednesday, October 6, 2021
Meat, Restaurant, Google Play, Diagnosis, Cheese, Ovarian cancer, OCRA, LinkedIn, Senior, National Institute of Construction Management and Research, Ovarian Cancer Research Alliance, Twitter, App store, Facebook, Executive, Newk's Eatery, List of The Price Is Right pricing games, BBQ, Salmon, Microwave, Protein, Signature, Fast food

Newk's new menu features a new look and delicious new items, including:

Key Points: 
  • Newk's new menu features a new look and delicious new items, including:
    Newk's Cheesesteak Sandwichmade with medium-rare petite tenderloin steak, Newk's signature pimiento cheese, cheddar cheese, red and yellow bell peppers, caramelized onions and mayoon Parisian bread.
  • Portabella Veggie Sandwich made withportabella mushrooms, red and yellow bell peppers, Swiss cheese and basil pesto on Parisian bread.
  • "In consumer research, we learned that our fans want more unique and craveable menu items in addition to our already popular menu lineup," said Newk's Senior Vice President of Guest Experience Denise Pedini.
  • "These new items continue that tradition, and we are certain they are going to become favorites for a new generation of Newk's fans."

Ovarian CanceRx: New Innovative Clinical Research Effort Seeks to Accelerate the Development of New Treatments for Deadliest Gynecological Cancer

Retrieved on: 
Thursday, September 23, 2021
Research, Women, Clinical Trials, Biotechnology, Health, Consumer, Pharmaceutical, Science, Oncology, Clinical trial, Partnership, Human, Research, Capitol Hill, Efficiency, MIT, Ovarian cancer, Patient, Coalition, Therapy, Cancer, Multimedia, Laboratory, OCRA, Ovarian Cancer Research Alliance, CEO, Woman, Disease, Finance, Drug development, Survival, Massachusetts Institute of Technology, Breast cancer, Industry, Pharmaceutical industry, Birth control, Global Coalition for Adaptive Research (GCAR), Ovarian Cancer Research Alliance (OCRA), Clearity Foundation, GLOBAL COALITION FOR ADAPTIVE RESEARCH (GCAR), OVARIAN CANCER RESEARCH ALLIANCE (OCRA), CLEARITY FOUNDATION

Working in collaboration with key members of the research, clinical and patient advocacy communities, Ovarian CanceRx capitalizes on novel drug development to give ovarian cancer patients access to potentially beneficial treatments at a time when they need them most now!

Key Points: 
  • Working in collaboration with key members of the research, clinical and patient advocacy communities, Ovarian CanceRx capitalizes on novel drug development to give ovarian cancer patients access to potentially beneficial treatments at a time when they need them most now!
  • While there are numerous randomized control trials in ovarian cancer, there are still significant unmet clinical needs in this field.
  • A key stakeholder in the effort is Ovarian Cancer Research Alliance (OCRA), the worlds largest ovarian cancer charity.
  • Through GCARs Ovarian CanceRx partnership we are gratified to support an innovative clinical trial design that will improve treatment for women with ovarian cancer.